alter
pain
sensat
hyperalgesia
allodynia
characterist
featur
variou
pain
state
remain
difficult
treat
shown
previous
spinal
applic
dipeptidyl
peptidas
inhibitor
induc
strong
antihyperalges
effect
inflammatori
pain
studi
observ
low
level
mrna
rat
spinal
dorsal
horn
physiolog
condit
chang
significantli
either
carrageenaninduc
inflammatori
partial
nerv
ligationgener
neuropath
state
anim
microglia
astrocyt
express
protein
one
two
order
magnitud
higher
neuron
respect
significantli
increas
astrocyt
inflamm
microglia
neuropathi
intrathec
applic
two
inhibitor
tripeptid
isoleucinprolinisoleucin
ipi
antidiabet
drug
vildagliptin
result
robust
opioiddepend
antihyperalges
effect
inflamm
milder
signific
opioidindepend
antihyperalges
action
neuropath
model
opioidmedi
antihyperalges
effect
ipi
exclus
relat
muopioid
receptor
vildagliptin
affect
mainli
deltareceptor
activ
although
muand
kappareceptor
also
involv
none
inhibitor
influenc
allodynia
result
suggest
patholog
gliatyp
specif
chang
activ
spinal
cord
contribut
develop
mainten
hyperalgesia
interact
endogen
opioid
system
type
ii
integr
transmembran
glycoprotein
express
mani
cell
type
appear
also
solubl
form
bodi
fluid
includ
cerebrospin
fluid
serin
proteas
cleav
dipeptid
oligopeptid
protein
contain
prolinealanin
penultim
posit
process
neuropeptid
hormon
cytokin
chemokin
lead
biolog
activ
inactiv
potenti
substrat
includ
incretin
glucagonlik
glucosedepend
insulinotrop
polypeptid
bradykinin
substanc
p
sp
neuropeptid
npi
vasoact
intestin
polypeptid
vip
tumour
necrosi
factor
addit
enzymat
activ
bind
site
adenosin
deaminas
ada
publish
xx
xx
xxxx
open
wwwnaturecomscientificreport
scientif
report
differ
extracellular
matrix
protein
like
collagen
fibronectin
also
known
cell
surfac
antigen
tlymphocyt
receptor
coronavirus
incretin
familiar
substrat
sinc
hormon
major
regul
postprandi
insulin
secret
inhibit
increas
incretin
level
prolong
postprandi
insulin
action
therefor
becom
major
target
therapi
type
ii
diabet
applic
newli
develop
inhibitor
reveal
sever
physiolog
patholog
process
lipid
metabol
myocardi
renal
liver
function
atherosclerosi
inflamm
involv
control
chronic
pain
associ
tissu
injuri
inflamm
ongo
diseas
made
progress
decad
current
analges
best
moder
effect
associ
intoler
side
effect
therefor
develop
novel
therapeut
intervent
pain
relief
one
chief
challeng
medic
scienc
well
establish
alter
pain
sensat
hyperalgesia
increas
respons
noxiou
stimuli
allodynia
pain
respons
normal
innocu
stimuli
spontan
pain
characterist
featur
variou
pain
state
previous
demonstr
dramat
reduct
mechan
hyperalgesia
follow
spinal
applic
inhibitor
ipi
vildagliptin
subacut
inflamm
action
naloxon
revers
suggest
opioid
receptormedi
effect
none
inhibitor
chang
nocicept
threshold
acut
nocicept
tailflick
test
analges
antiinflammatori
effect
inhibitor
also
show
chronic
inflammatori
model
mice
machineri
endogen
opioid
system
intens
investig
clarifi
recent
decad
although
inducingregul
endogen
opioid
machineri
would
provid
power
tool
control
pain
propag
possibl
remain
larg
unexploit
identifi
spinal
dorsal
horn
show
express
chang
patholog
condit
demonstr
shape
opioid
signal
receptorand
treatmentspecif
manner
although
synapt
may
key
role
neuron
mechan
pain
propag
identifi
glial
cell
induc
way
play
role
hyperalgesia
opioid
signal
transcript
rat
spinal
dorsal
horn
physiolog
inflammatori
neuropath
state
taqman
qpcr
detect
mrna
dorsal
horn
spinal
segment
taken
control
inflam
neuropath
rat
neither
carrageenan
treatment
neuropath
condit
caus
signific
alter
mrna
level
rel
quantiti
control
carrageenaninduc
inflamm
neuropath
group
vs
vs
oneway
anova
p
fig
mrna
show
low
express
situ
hybrid
spinal
dorsal
horn
segment
grain
densiti
observ
section
hybrid
use
sens
probe
equal
background
signific
signal
detect
antisens
probe
antisens
n
median
sens
n
median
mannwhitney
rank
sum
test
p
mrna
distribut
evenli
within
dorsal
horn
signific
differ
among
experiment
group
detect
control
n
inflam
n
neuropath
n
oneway
anova
p
fig
data
obtain
qpcr
situ
hybridis
studi
clearli
demonstr
mrna
exist
spinal
dorsal
horn
quantiti
chang
either
inflammatori
neuropath
pain
state
protein
express
physiolog
condit
chang
inflamm
neuropathi
spinal
dorsal
horn
western
blot
band
pattern
origin
rat
spinal
dorsal
horn
appear
similar
one
taken
human
white
pre
adipocyt
use
antibodi
differ
one
use
current
experi
westernblot
analysi
studi
demonstr
elev
protein
level
inflam
spinal
cord
significantli
differ
found
neuropath
spinal
cord
control
inflam
neuropath
oneway
anova
holmsidak
method
p
fig
immunoreact
spinal
cord
appear
inflam
also
neuropath
anim
densitometri
immunolabel
show
signific
increas
medial
two
third
dorsal
horn
correspond
hind
paw
inflamm
compar
neuropath
condit
control
n
inflam
n
neuropath
n
oneway
anova
p
fig
contrast
mrna
overal
amount
protein
detect
westernblot
immunohistochemistri
significantli
increas
spinal
dorsal
horn
inflamm
chang
neuropathi
compar
physiolog
state
immunoreact
chang
individu
cell
type
patholog
punctat
immunostain
detect
neuron
cell
bodi
fig
also
axon
termin
naiv
anim
puncta
repres
embed
synaptophysin
stain
element
suggest
close
relationship
synapt
activ
mani
case
fig
dot
appear
surfac
label
dendrit
alway
associ
synaptophysin
posit
fig
suggest
dendrit
express
enzym
receiv
synaps
bouton
enzym
appear
vesicular
glutam
transport
immunolabel
excitatori
fig
vesicular
gaba
transport
vgat
posit
inhibitori
axon
termin
fig
well
cgrp
stain
primari
affer
bouton
fig
label
also
occur
gfapposit
astrocyt
fig
microglia
cell
fig
naiv
rat
densiti
enzym
stain
highest
astrocyt
differ
significantli
cell
type
densiti
also
significantli
higher
microglia
neuron
astrocyt
n
median
kruskalw
oneway
anova
rank
dunn
method
p
case
n
mean
number
analys
optic
section
neuron
glial
element
note
immunolabel
exist
membran
differ
cell
type
also
intracellular
compart
take
qualit
quantit
data
togeth
tabl
fig
immunostain
detect
neuron
cell
bodi
also
excitatori
inhibitori
axon
termin
anim
densitometr
analysi
show
anim
microglia
astrocyt
express
protein
one
two
order
magnitud
higher
neuron
respect
furthermor
express
significantli
increas
astrocyt
chang
cell
type
inflamm
neuropath
condit
immunoreact
significantli
increas
microglia
decreas
neuron
remain
unchang
astrocyt
challeng
involv
opioid
receptor
type
select
opioid
receptor
antagonist
appli
spinal
togeth
two
differ
inhibitor
carrageenaninduc
subacut
inflamm
applic
nmolrat
ipi
nmolrat
vildagliptin
elimin
mechan
hyperalgesia
measur
randallselitto
test
intraplantar
carrageenaninduc
inflamm
coadministr
muopioid
receptor
mor
select
inhibitor
ctap
reduc
antihyperalges
effect
ipi
follow
coapplic
kappareceptor
kor
antagonist
gnti
deltaopioid
receptor
dor
antagonist
tipp
antihyperalges
effect
ipi
remain
respect
follow
coadministr
muand
kappaantagonist
antihyperalges
effect
vildagliptin
respect
deltaantagonist
tipp
complet
block
antihyperalges
effect
vildagliptin
reduc
antihyperalges
effect
fig
result
show
ipi
vildagliptin
result
robust
distinct
opioiddepend
antihyperalges
effect
inflamm
antihyperalges
effect
ipi
fulli
block
select
muopioid
receptor
antagonist
decreas
observ
select
kappaand
deltaantagonist
case
vildagliptin
antihyperalges
effect
inhibitor
complet
block
select
deltareceptor
antagonist
select
muand
kappareceptor
antagonist
also
decreas
effect
significantli
effect
inhibitor
neuropathi
differ
modal
hyperalgesia
allodynia
appear
inflammatori
condit
also
neuropath
pain
state
none
test
inhibitor
signific
effect
mechan
cold
allodynia
ipi
vildagliptin
signific
mechan
antihyperalges
effect
measur
randallselitto
test
one
week
partial
sciatic
nerv
ligat
mpe
valu
respect
contrast
inflammatori
state
nonselect
opiat
antagonist
naltrexon
ntx
affect
antihyperalges
action
inhibitor
signifficantli
neuropath
condit
suggest
complet
differ
action
enzym
hyperalgesia
two
pain
state
fig
high
level
express
develop
brain
spinal
cord
describ
dramat
decreas
adult
persist
leptomening
cell
capillari
endotheli
cell
choroid
plexu
mrna
detect
cortic
area
adult
anim
level
chang
cerebr
ischemia
contrast
immunoreact
found
region
physiolog
state
express
appear
microglia
neuron
astrocyt
differ
time
point
cerebr
ischaemia
first
show
transcript
well
protein
detect
adult
mammalian
spinal
dorsal
horn
similarli
effect
ischem
injuri
brain
qpcr
situ
hybrid
analysi
show
mrna
level
influenc
inflamm
neuropathi
spinal
dorsal
horn
treatment
howev
caus
mark
chang
protein
level
region
inflam
caus
fivefold
increas
protein
level
suggest
potent
posttranscript
control
express
quickli
develop
inflamm
ischemia
neuron
glia
understand
molecular
regul
far
complet
studi
lymphocyt
demonstr
retino
acid
interferon
administr
result
increas
transcript
upregul
translat
mere
decreas
cell
surfac
express
suggest
complex
mechan
regul
activ
high
resolut
confoc
laser
scan
imag
reveal
neuron
typic
confin
presynapt
also
somat
domain
significantli
decreas
densiti
neuropathi
contrast
astrocyt
ampli
decor
profil
significantli
increas
densiti
inflammatori
neuropath
state
final
thirdparti
involv
spinal
neuropath
mechan
like
figur
immunoreact
variou
type
axon
termin
immunolabel
dendrit
surfac
associ
synaptophysin
syn
indic
dendrit
axon
termin
express
receptor
row
express
major
peptiderg
cgrpcontain
c
primari
affer
termin
row
b
coexpress
syn
row
c
vgat
row
suggest
present
excitatori
inhibitori
nerv
end
imag
singl
optic
section
scalebar
reflect
increas
express
microglia
show
obviou
protein
express
level
control
anim
detect
level
protein
healthi
spinal
cord
contrast
brain
tissu
could
due
quick
ondemand
regulatori
role
moonlight
protein
nocicept
process
sp
npi
offer
ampl
typic
substrat
presynapt
locat
neuron
suggest
possibl
role
protein
synapt
physiolog
hand
glial
express
significantli
upregul
patholog
cell
type
specif
manner
open
aspect
detect
altern
role
protein
differ
pain
state
previous
demonstr
inhibitor
chang
nocicept
threshold
acut
nocicept
condit
contrast
robust
antihyperalges
effect
differ
inhibitor
ipi
vildagliptin
sitagliptin
carrageenaninduc
complet
freund
adjuv
cfa
provok
chronic
inflammatori
model
report
previous
addit
mechan
heat
hyperalgesia
mechan
heat
allodynia
may
also
exist
carrageenaninduc
inflammatori
model
two
modal
allodynia
measur
studi
sinc
effect
nonnoxi
heat
mechan
stimuli
detect
precis
extrem
larg
paw
swell
hand
touch
sensit
measur
dynam
plantar
aesthesiometri
dpa
cfainduc
chronic
inflammatori
model
show
neuropath
c
anim
demonstr
express
predominantli
glial
cell
arrow
microglia
arrowhead
astrocyt
imag
singl
optic
section
scalebar
integr
densiti
valu
demonstr
major
relat
gfaplabel
astrocyt
proport
label
belong
microgila
express
neuron
cell
bodi
inflamm
significantli
increas
express
astocyt
cell
type
contrast
inflamm
densiti
significantli
higher
microglia
lower
neuron
neuropathi
kruskalw
one
way
anova
rank
dunn
method
p
antihyperalges
action
ipi
vildagliptin
appear
opioidmedi
carrageenaninduc
inflamm
sinc
nonselect
opioid
receptor
antagonist
naloxonenaltrexon
revers
effect
studi
examin
opioid
receptor
involv
use
select
antagonist
mor
dor
kor
measur
mechan
hyperalgesia
carrageenaninduc
acut
inflamm
surprisingli
antihyperalges
effect
ipi
exclus
relat
mor
vildagliptin
affect
mainli
dor
also
effect
mor
kor
demonstr
previous
ipi
activ
mor
directli
ipi
vildagliptin
inhibitor
ipi
penultim
prolin
also
substrat
enzym
competit
inhibit
kinet
artefact
although
inhibitor
target
activ
site
enzym
extent
inhibit
depend
residu
interact
drug
activ
site
residu
xray
crystallographi
analys
cocryst
structur
differ
inhibitor
demonstr
inhibitor
substrat
could
bind
well
beyond
subsit
increas
inhibitori
activ
take
togeth
support
differ
residu
interact
two
inhibitor
affect
activ
differ
way
endogen
opioid
especi
enkephalin
dynorphin
endorphin
releas
spinal
supraspin
site
acut
inflamm
degrad
quickli
extrem
high
enzymat
activ
common
featur
opioid
activ
opioid
receptor
differ
potenc
inhibitori
effect
opioid
antagonist
ipi
vildagliptin
relat
antihyperalgesia
summar
bar
graph
g
h
construct
data
record
min
drug
applic
comparison
made
twoway
anova
bonferoni
post
hoc
test
p
p
af
oneway
anova
follow
dunnett
post
hoc
test
p
g
h
asterisk
alway
indic
signific
differ
timematch
point
inhibitor
inhibitor
opioid
antagonist
curv
data
curv
bar
given
mean
sem
sinc
ipi
vildagliptin
select
inhibitor
unlik
inhibitori
effect
opioid
degrad
enzym
hand
demonstr
glial
cell
express
opioid
receptor
synthes
endogen
opioid
process
least
partli
regul
inflammatori
mediat
includ
interact
two
system
mutual
sinc
endogen
opioid
also
effect
product
inflammatori
mediat
releas
glial
cell
glucagonlik
receptor
activ
result
releas
microglia
block
inflammatori
nocicept
mechan
allodynia
spinal
nerv
ligat
model
studi
found
increas
express
microglia
astrocyt
facilit
degrad
mani
peptid
includ
system
increas
peptid
detect
inflamm
ipivildagliptin
block
activ
may
increas
level
spinal
cord
induc
releas
microglia
studi
found
substanti
increas
express
astrocyt
inflamm
also
demonstr
astrocyt
synthes
proenkephalin
dynorphin
make
good
candid
sourc
peptid
shown
purinerg
tolllik
receptor
tlr
activ
result
dynorphina
b
releas
glia
type
proenkephalin
releas
also
detect
cultur
astrocyt
howev
condit
astrocyt
releas
proenkephalin
vivo
determin
recent
vitro
studi
monocyt
demonstr
inhibitor
suppress
mediat
upregul
proinflammatori
cytokin
includ
inflammasom
key
molecul
figur
antinocicept
effect
inhibitor
ipi
vildagliptin
chronic
neuropath
condit
induc
partial
sciatic
nerv
ligat
inhibitor
ineffect
dynam
plantar
aesthesiomet
noxiou
cold
sensit
b
e
test
randallselitto
test
ipi
vildagliptin
antihyperalges
effect
antagon
ntx
c
f
maxim
possibl
effect
mpe
inhibitor
alon
combin
subtyp
specif
opioid
antagonist
given
bar
graph
gi
comparison
made
twoway
anova
bonferoni
post
hoc
test
p
p
p
af
oneway
anova
follow
dunnett
post
hoc
test
p
p
gi
data
curv
bar
given
mean
sem
scientif
report
process
releas
extracellularregul
kinas
erk
activ
also
critic
role
express
inflammatori
cytokin
data
suggest
import
interact
activ
may
exist
also
glial
cell
regul
synthesi
releas
inflammatori
mediat
endogen
opioid
partial
nerv
injuri
one
main
root
caus
causalgiform
pain
disord
human
partial
ligat
sciatic
nerv
model
pain
state
result
mechan
hyperalgesia
togeth
mechan
cold
allodynia
although
alter
pain
sensat
characterist
featur
inflammatori
neuropath
pain
state
distinct
anatom
molecular
mechan
well
signal
pathway
could
activ
therefor
inhibitor
also
test
model
ipi
vildagliptin
produc
signific
decreas
mechan
hyperalgesia
effect
opioiddepend
compar
extent
antihyperalges
effect
inhibitor
inflamm
neuropathi
may
suggest
inhibitor
effect
inflammatori
condit
neuropat
state
howev
must
emphas
neuropath
pain
hyperalgesia
difficult
treat
efficaci
inhibitor
compar
adjuv
analges
refer
drug
use
clinic
practic
dose
caus
sed
sideeffect
motor
incoordin
therefor
moder
signific
antihyperalges
action
inde
consid
remark
addit
mechan
hyperalgesia
mechan
cold
allodynia
also
appear
neuropathi
none
inhibitor
affect
either
type
allodynia
sever
model
differ
type
allodynia
hyperalgesia
propos
common
featur
two
phenomena
base
differ
mechan
major
issu
whether
special
design
behaviour
test
mechan
allodynia
mechan
hyperalgesia
reflect
phenomena
studi
thresholddecreas
determin
randallselitto
test
appli
basic
pain
pressur
stimulu
rat
hind
paw
expect
show
mechan
hyperalgesia
touch
stimulu
appli
dpa
util
bluntend
metal
needl
consid
nonpain
intact
normal
condit
therefor
thresholddecreas
expect
reflect
mechan
allodynia
sinc
spinal
applic
two
inhibitor
result
signific
chang
randallselitto
test
dpa
data
indic
two
test
measur
two
differ
process
therefor
conclud
inhibitor
select
affect
hyperalgesia
allodynia
result
indic
contribut
develop
mainten
mechan
hyperalgesia
model
neuropathi
underli
mechan
unknown
increas
express
enzym
obviou
microglia
suggest
role
cell
type
process
contribut
microglia
develop
allodynia
neuropath
condit
intens
studi
role
induct
maintan
hyperalgesia
relationship
requir
studi
studi
demonstr
express
spinal
cord
similarli
higher
brain
area
express
significantli
chang
patholog
condit
inhibitor
enzym
affect
acut
nocicept
process
allodynia
select
block
glial
mechan
contribut
develop
mainten
hyperalgesia
inflammatori
neuropath
condit
rais
possibl
inhibitor
target
central
nervou
system
could
import
antihyperalges
antiinflammatori
compon
new
analges
treatment
sever
persist
pain
without
seriou
side
effect
anim
nocicept
threshold
measur
carri
male
wistar
rat
weigh
g
receiv
breed
coloni
semmelwei
univers
use
carrageenan
induc
hyperalgesia
model
anim
weigh
g
start
partial
sciatic
nerv
ligat
experi
seltzer
model
pain
pressur
stimulu
rat
hind
paw
show
mechan
hyperalgesia
touch
stimulu
appli
dynam
plantar
aesthesiometri
dpa
use
bluntend
metal
needl
consid
nonpain
intact
normal
condit
therefor
threshold
decreas
reflect
mechan
allodynia
chang
withdraw
latenc
icecold
water
reflect
cold
allodynia
carrageenaninduc
subacut
inflamm
inflamm
induc
intraplantar
inject
l
dissolv
salin
sigmaaldrich
right
hindpaw
nocicept
threshold
pressur
determin
randallselitto
method
use
type
analgesimet
ugo
basil
comerio
itali
rat
lightli
restrain
evenli
increas
forc
appli
onto
paw
insert
coneshap
clamp
apparatu
moment
paw
withdraw
actual
forc
record
nocicept
threshold
baselin
nocicept
threshold
initi
determin
hindpaw
min
carrageenan
inject
right
hindpaw
min
nocicept
threshold
measur
min
inject
vehicl
inhibitor
alon
ipi
vil
combin
subtyp
specif
opioid
receptor
antagonist
ctap
tipp
gnti
perform
cardin
sign
inflamm
red
swell
heat
paw
obviou
second
measur
start
nocicept
threshold
read
repeat
minut
five
rat
involv
vehicl
experi
anim
use
drug
drug
combin
timematch
data
set
differ
ipsilater
curv
compar
twoway
repeat
measur
anova
follow
bonferroni
post
hoc
test
percentag
maximum
possibl
antihyperalges
effect
calcul
accord
follow
equat
mpe
ipsilater
threshold
min
drug
applic
hyperalges
baselin
contralater
threshold
time
hyperalges
baselin
hyperalges
baselin
defin
nocicept
threshold
inflam
hindpaw
min
intraplantar
carrageenan
inject
comparison
made
oneway
anova
follow
dunnett
post
hoc
test
partial
sciatic
nerv
ligationinduc
chronic
neuropath
pain
model
traumat
mononeuropathi
partial
ligat
sciatic
nerv
result
mechan
hyperalgesia
togeth
mechan
cold
allodynia
accordingli
baselin
nocicept
threshold
determin
two
consecut
day
use
dynam
plantar
aestesiometri
dpa
mechan
allodynia
noxiou
cold
stimul
cold
allodynia
randallselitto
test
mechan
hyperalgesia
deep
pentobarbit
anesthesia
mgkg
ip
euthasol
produlab
pharma
raamsdonksv
netherland
sciatic
nerv
rat
n
tightli
ligat
high
thigh
unilater
use
braid
silk
sutur
mersilk
ethicon
approxim
diamet
nerv
trap
ligatur
wound
close
afterward
silk
sutur
anim
allow
recov
one
week
th
postop
day
nocicept
threshold
measur
repeat
anim
short
interv
percentag
hyperalgesiaallodynia
valu
calcul
nerveinjur
paw
follow
formula
hyperalgesiaallodynia
preoper
postop
valu
preoper
valu
anim
develop
minimum
decreas
threshold
method
includ
treatment
group
n
rat
arrang
group
similar
degre
hyperalgesiaallodynia
receiv
vehicl
inhibitor
inhibitor
min
sc
ntx
pretreat
vehicl
inhibitor
experi
anim
use
group
group
undergo
inhibitor
applic
follow
sc
ntx
pretreat
consist
rat
nocicept
measur
anim
carri
min
inject
start
dpa
min
follow
randallselitto
test
min
finish
noxiou
cold
stimul
min
dynam
plantar
aesthesiometri
rat
place
observ
chamber
posit
metal
mesh
surfac
touch
stimul
unit
place
anim
paw
increas
upward
forc
gs
exert
rat
remov
paw
withdraw
threshold
measur
time
turn
hindpaw
mean
valu
use
statist
analysi
withdraw
occur
preset
maximum
g
use
evalu
randallselitto
test
perform
detail
measur
noxiou
cold
sensit
hindpaw
lightli
restrain
rat
immers
water
bath
latenc
paw
withdraw
record
cutoff
time
set
second
withdraw
threshold
record
nerv
ligat
th
postop
day
drug
applic
compar
twoway
repeat
measur
anova
follow
bonferroni
post
hoc
test
percent
maximum
possibl
effect
calcul
accord
follow
formula
mpe
withdraw
threshold
drug
applic
withdraw
threshold
nerv
ligat
withdraw
threshold
drug
applic
withdraw
threshold
nerv
ligat
comparison
made
oneway
anova
follow
dunnett
post
hoc
test
carrageenan
inject
hindpaw
rat
partial
ligat
sciatic
nerv
perform
anim
surviv
time
hour
day
respect
develop
inflammatori
neuropath
hyperalgesia
confirm
randallselitto
test
rat
sacrif
decapit
anim
use
control
spinal
segment
remov
frozen
dri
ice
rna
isol
use
rneasi
lipid
tissu
mini
kit
qiagen
spinal
cord
sampl
accord
manufactur
instruct
puriti
concentr
rna
analyz
use
smartspec
plu
spectrophotomet
biorad
uk
revers
transcript
perform
rna
convert
total
rna
cdna
use
highcapac
cdna
revers
transcript
kit
appli
biosystem
life
technolog
concentr
gener
cdna
determin
use
qubit
commerci
avail
taqman
probe
cdna
templat
duplic
dehydrogenas
use
housekeep
gene
express
vari
experiment
group
statist
analys
qpcr
data
express
rel
quantif
valu
rq
mean
sem
compar
group
oneway
anova
situ
hybridis
bp
long
fragment
rat
cdna
gene
bank
access
purchas
blue
heron
biotechnolog
inc
bothel
wa
usa
subclon
pbc
ks
addgen
cambridg
usa
vector
verifi
sequenc
situ
hybridis
ish
perform
describ
earlier
riboprob
sens
antisens
direct
prepar
vitro
transcript
maxiscriptkit
life
technolog
carlsbad
ca
usa
label
use
utp
perform
hungaria
kft
budapest
hungari
carrageenan
inject
hindpaw
rat
partial
ligat
sciatic
nerv
perform
anim
surviv
time
hour
day
respect
develop
inflammatori
neuropath
hyperalgesia
confirm
randallselitto
test
rat
sacrif
decapit
anim
use
control
spinal
dorsal
horn
segment
remov
frozen
dri
ice
serial
coron
section
cut
cryostat
mount
onto
posit
charg
superfrost
plu
slide
life
technolog
slide
hybrid
overnight
humid
chamber
cpmslide
radioact
label
probe
wash
dehydr
slide
dip
ntb
nuclear
track
emuls
carestream
health
deutschland
gmbh
stuttgart
germani
week
emulsionco
slide
develop
use
kodak
dektol
develop
fixer
sigmaaldrich
kft
budapest
hungari
section
counterstain
giemsa
solut
sigma
air
dri
coverslip
use
depex
mount
medium
darkfield
imag
three
sampl
per
anim
captur
olympu
microscop
olympu
corpor
hamburg
germani
attach
qicam
qimag
surrey
bc
canada
camera
grain
densiti
indic
level
mrna
express
calcul
area
percent
occupi
silver
grain
within
given
region
interest
roi
pixel
use
imag
j
program
section
roi
background
area
outsid
tissu
roi
dorsal
horn
measur
averag
background
subtract
valu
obtain
tissu
sens
antisens
signal
compar
use
student
ttest
sigmastat
systat
softwar
inc
san
jose
ca
usa
one
way
anova
use
compar
antisens
situ
hybrid
signal
among
group
western
blot
five
rat
unilater
carrageenaninduc
hindpaw
inflamm
rat
undergo
unilater
partial
nerv
ligat
one
week
earlier
rat
test
randallselitto
method
describ
confirm
obviou
decreas
nocicept
threshold
anim
sacrif
decapit
spinal
dorsal
horn
segment
remov
snapfrozen
dri
ice
sampl
homogen
tne
buffer
contain
triton
sigma
mm
naf
na
vo
cocktail
proteas
inhibitor
completetm
roch
briefli
sonic
cell
debri
nuclei
pellet
centrifug
g
min
protein
concentr
determin
bradford
colorimetr
method
sampl
dilut
final
protein
concentr
denatur
laemmli
buffer
analys
sdspage
resolv
gel
transfer
onto
immobilonfl
polyvinyliden
difluorid
membran
millipor
membranebound
protein
sampl
block
bsa
dilut
tb
h
subsequ
expos
goat
primari
antibodi
tabl
overnight
signal
detect
achiev
use
hrpconjug
donkey
antigoat
secondari
antibodi
jackson
densitometr
data
normal
quantif
three
blot
per
treatment
use
imag
acquisit
analysi
perform
biorad
xr
imag
platform
immunofluoresc
label
antibodi
polyclon
goat
antibodi
rais
synthet
peptid
cpphfdkskkyp
repres
intern
region
accord
label
one
band
approx
kda
rat
lung
lysat
western
blot
experi
detail
see
supplier
datasheet
western
blot
experi
rat
lung
pancrea
lysat
use
posit
control
fig
monoclon
mous
antibodi
produc
full
length
rat
protein
test
specif
two
antibodi
doubl
immunofluoresc
stain
carri
antibodi
label
profil
neuron
astrocyt
microglia
fig
mous
antineuronspecif
nuclear
protein
neun
use
label
neuron
somata
togeth
neurotrac
bluefluoresc
nissl
stain
thermo
fischer
scientif
invitrogen
cat
dendrit
identifi
monoclon
mous
antibodi
produc
mice
microtubuleassoci
protein
antibodi
stain
one
singl
lane
kda
western
blot
experi
use
rat
brain
extract
ioniz
calciumbind
adaptor
use
specif
microgliamacrophag
marker
antibodi
isol
serum
rabbit
immun
synthet
peptid
correspond
cterminu
accord
provid
antibodi
stain
one
singl
lane
western
blot
experi
around
kda
monoclon
mous
antibodi
glial
fibrillari
acid
protein
gfap
use
specif
label
astrocyt
guinea
pig
antibodi
vesicular
glutam
transport
use
identifi
excitatori
axon
termin
antibodi
rais
amino
acid
long
sequenc
rat
protein
western
blot
analysi
rat
brain
lysat
show
kda
lane
seen
provid
datasheet
relat
lot
antibodi
heavili
use
well
character
inhibitori
bouton
label
polyclon
antibodi
vesicular
gaba
transport
vgat
rais
rabbit
immun
synthet
peptid
aeppvegdihyqr
amino
acid
rat
vgat
coupl
keyhol
limpet
hemocyanin
via
ad
ntermin
cystein
base
supplier
data
sheet
antibodi
knockout
verifi
synaptophysin
syn
use
synapt
marker
monoclon
mous
antibodi
rais
synthet
peptid
correspond
region
near
ctermin
end
full
peptid
syn
antibodi
valid
immunohistochemistri
western
blot
found
human
protein
atla
http
wwwproteinatla
org
calcitonin
generel
peptid
cgrp
antibodi
rais
guinea
pig
use
label
peptiderg
unmyelin
primari
affer
recogn
ident
structur
detect
well
character
rabbit
goat
antibodi
rat
detail
specif
antibodi
see
tabl
secondari
antibodi
rais
donkey
alexa
fluor
af
label
antigoat
conjug
antimous
label
antirabbit
thermo
fischer
scientificinvitrogenmolecular
probe
rhodamin
red
xanti
guinea
pig
cyanin
mous
cyanin
rabbit
jackson
immunoresearch
gener
immunofluoresc
stain
protocol
transcardi
perfus
deepli
anesthet
mg
ketamin
mg
xylazin
im
rat
naiv
unilater
carrageenan
treat
unilater
nerv
ligat
describ
initi
para
formaldehyd
complet
para
formaldehyd
contain
sucros
spinal
segment
remov
immers
overnight
sucros
dissolv
pb
segment
frozen
liquid
nitrogen
thick
section
cut
vibratom
endogen
peroxidas
activ
block
minut
hydrogen
peroxid
dilut
phosphat
buffer
pb
section
transfer
phosphat
buffer
salin
pb
normal
hors
serum
nh
block
procedur
incub
overnight
antibodi
react
alexa
fluor
label
speci
specif
secondari
antibodi
section
incub
hour
mixtur
primari
antibodi
react
overnight
fluoresc
label
speci
specif
secondari
antibodi
primari
secondari
antibodi
dissolv
pb
set
experi
section
immers
neurotrac
fluoresc
nissl
dye
invitrogenmolecular
probe
phosphat
buffer
half
hour
mount
rins
section
mount
vectashield
vector
laboratori
scan
confoc
laser
scan
system
zeiss
densitometri
immunostain
spinal
cord
segment
taken
control
carrageenantr
nervelig
rat
use
quantit
analysi
three
six
spinal
cord
section
taken
segment
basi
gray
matter
shape
confoc
optic
section
scan
section
stain
view
prior
select
section
roi
cell
profil
quantit
analysi
carri
independ
observ
blind
experiment
condit
involv
scan
either
determin
immunoreact
alter
differ
circumst
field
contain
whole
dorsal
horn
scan
len
confoc
microscop
produc
zstack
z
separ
scan
paramet
select
optim
section
control
anim
use
section
treat
rat
singl
optic
section
contain
black
white
imag
select
zseri
analys
use
imag
j
program
rasband
ws
imag
j
nih
bethesda
maryland
medial
two
third
dorsal
horn
contain
first
four
lamina
area
receiv
input
sciatic
nerv
drawn
section
use
region
interest
roi
threshold
adjust
densiti
immunostain
calcul
area
percentag
occupi
immunostain
dot
within
given
roi
data
compar
among
group
oneway
anova
analys
densiti
immunoreact
individu
cell
type
nonoverlap
field
within
medial
two
third
spinal
dorsal
horn
scan
oil
immers
len
gener
zstack
zsepar
optim
paramet
use
type
section
gfapand
glial
cell
immunolabel
fluoresc
nissl
stain
neuron
cell
bodi
imag
differ
colour
channel
sequenti
outlin
microglia
astrocyt
determin
automat
use
autothreshold
plugin
imagej
gfap
imag
channel
respect
exclud
nonspecif
label
glial
cell
nuclei
fluoresc
nissl
dye
contour
randomli
select
neuron
neuronfield
drawn
manual
integr
densiti
valu
imag
channel
measur
previous
delin
glial
neuron
profil
detect
chang
protein
express
due
differ
treatment
densiti
valu
subject
statist
analysi
statist
analysi
statist
method
use
detail
experi
individu
analys
made
sigmastat
systat
softwar
inc
san
jose
ca
usa
curvesbar
graph
creat
graphpad
prism
softwar
graphpad
softwar
inc
la
jolla
ca
usa
gener
data
repres
mean
sem
popul
normal
distribut
median
otherwis
case
p
consid
statist
signific
data
avail
dataset
gener
analys
current
studi
avail
correspond
author
reason
request
